Vous avez sélectionné la vue dans Anglais
Descripteur en français: | Lévamisole | ||||||
Descripteur en anglais: | Levamisole | ||||||
Descripteur en espagnol: |
Levamisol
| ||||||
Descripteur en portugais: | Levamisol | ||||||
Synonymes: |
Decaris Dekaris Hydrochloride, Levamisole L-Tetramisole Levamisole Hydrochloride Levotetramisole Solaskil |
||||||
Code(s) d'arborescence: |
D02.886.675.346 D03.383.129.308.480 D03.383.129.708.346 |
||||||
Identificateur unique RDF: | https://id.nlm.nih.gov/mesh/D007978 | ||||||
Note d'application: | An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) |
||||||
Qualificatifs autorisés: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Action Pharmacologique: |
Adjuvants immunologiques Antihelminthiques antinématodes Antirhumatismaux |
||||||
Numéro de registre: | 2880D3468G | ||||||
Nom CAS Type 1: | Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (S)- | ||||||
Note publique MeSH: | 74 |
||||||
Note historique: | 74 |
||||||
Identifiant DeCS: | 28126 | ||||||
ID du Descripteur: | D007978 | ||||||
Documents indexés dans la Biblioteque Virtuelle de Santé (BVS): | Cliquez ici pour accéder aux documents VHL | ||||||
Date d'établissement: | 01/01/1974 | ||||||
Date d'entrée: | 01/01/1999 | ||||||
Date de révision: | 31/05/2016 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Levamisole
- Concept préféré
Levamisole Hydrochloride
- Plus spécifique
Solaskil
- Plus spécifique
Dekaris
- Plus spécifique
Concept UI |
M0012431 |
Note d'application | An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6) |
Terme préféré | Levamisole |
Synonymes |
L-Tetramisole Levotetramisole |
Concept UI |
M0330203 |
Terme préféré | Levamisole Hydrochloride |
Synonymes |
Hydrochloride, Levamisole |
Concept UI |
M0353243 |
Terme préféré | Solaskil |
Concept UI |
M0012432 |
Terme préféré | Dekaris |
Synonymes |
Decaris |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey